Ingevity director granted 1,904 deferred stock units

Ingevity Corp director Bruce D. Hoechner received a grant of 1,904 deferred stock units (DSUs) of Common Stock as equity compensation.

Rhea-AI Filing Summary

Ingevity Corp director Bruce D. Hoechner received a grant of 1,904 deferred stock units (DSUs) of Common Stock as equity compensation. The award was made in lieu of the annual non-employee director restricted stock unit grant and carries no cash exercise price.

The DSUs will vest on April 30, 2027 and will convert into an equal number of Ingevity Common Stock shares when his board service ends, under the company’s Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. Following this grant, Hoechner directly holds 10,732 shares.

Insider Trade Summary

Grant/Award: 1,904 shares

Grant/Award 1 txn

Insider Hoechner Bruce D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,904	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,732 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of deferred stock units ("DSUs") issued pursuant to the reporting person's election to receive DSUs in lieu of the annual non-employee director restricted stock unit grant. These DSUs will vest on April 30, 2027 and will settle into an equal number of shares of the issuer's Common Stock upon the reporting person's termination of board service pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.

Key Figures

Deferred stock units granted: 1,904 units Shares held after transaction: 10,732 shares Grant price per share: $0.0000 per unit +1 more

4 metrics

Deferred stock units granted 1,904 units Equity award to director Bruce D. Hoechner

Shares held after transaction 10,732 shares Hoechner’s direct Common Stock holdings post-grant

Grant price per share $0.0000 per unit DSUs issued as compensation, no cash purchase

Vesting date April 30, 2027 DSUs vest on this date under plan terms

Key Terms

deferred stock units, Non-Employee Director Deferred Compensation Plan, 2025 Omnibus Incentive Plan, restricted stock unit grant

4 terms

deferred stock units financial

"Represents a grant of deferred stock units ("DSUs") issued pursuant to the reporting person's election"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Non-Employee Director Deferred Compensation Plan financial

"upon the reporting person's termination of board service pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan"

2025 Omnibus Incentive Plan financial

"pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

restricted stock unit grant financial

"in lieu of the annual non-employee director restricted stock unit grant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ingevity (NGVT) report for Bruce D. Hoechner?

Ingevity reported that director Bruce D. Hoechner received 1,904 deferred stock units of Common Stock as an equity award. The grant was made in lieu of his annual non-employee director restricted stock unit grant and involves no cash purchase price.

How many Ingevity (NGVT) shares does Bruce D. Hoechner hold after this Form 4?

After the reported grant, Bruce D. Hoechner directly holds 10,732 shares of Ingevity Common Stock. This reflects the updated ownership position shown in the Form 4 following receipt of 1,904 deferred stock units as part of his director compensation.

When do Bruce D. Hoechner’s Ingevity (NGVT) deferred stock units vest?

The 1,904 deferred stock units granted to Bruce D. Hoechner vest on April 30, 2027. Vesting means the award becomes fully earned at that date, subject to the terms of Ingevity’s Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.

How will the Ingevity (NGVT) deferred stock units be settled for Bruce D. Hoechner?

Upon Bruce D. Hoechner’s termination of board service, his vested deferred stock units will settle into an equal number of Ingevity Common Stock shares. Settlement timing is tied specifically to the end of his service as a director under the company’s compensation plans.

What plans govern Bruce D. Hoechner’s Ingevity (NGVT) deferred stock unit grant?

The deferred stock unit grant to Bruce D. Hoechner is issued under Ingevity’s Amended and Restated Non-Employee Director Deferred Compensation Plan and its 2025 Omnibus Incentive Plan, which together define vesting, settlement mechanics, and other key award terms for non-employee directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 06:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoechner Bruce D.

(Last) (First) (Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON SOUTH CAROLINA 29405

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		A		1,904(1)	A	$0	10,732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of deferred stock units ("DSUs") issued pursuant to the reporting person's election to receive DSUs in lieu of the annual non-employee director restricted stock unit grant. These DSUs will vest on April 30, 2027 and will settle into an equal number of shares of the issuer's Common Stock upon the reporting person's termination of board service pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.

Remarks:

	Bruce D. Hoechner By: Mavis G. Huger as Attorney-in-Fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)